drugset
Drugs / Nociceptin Receptor Antagonist
last change Feb 2025 re-read 3 minutes ago

Nociceptin Receptor Antagonist

Developed for
anxiety disorder · major depressive disorder
Investigated by
Brown University · Massachusetts General Hospital · Massachusetts Institute of Technology · Mclean Hospital · National Institute of Mental Health (NIMH) · University of Washington

Trials 1

today NCT05232032 · Ph 2
20262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT05232032 Feb 2025 → Mar 2027 expected anxiety disorder, major depressive disorder Mclean Hospital Recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Nociceptin Receptor Antagonist ClinicalTrials.gov intervention name — accepted as the source's own label NCT05232032 ↗
Action Inhibit “nociceptin receptor antagonist” NCT05232032 ↗